Are you Dr. Ryerson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 5 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Ave
# M1087
San Francisco, CA 94143Fax+1 415-476-5712
Summary
- Dr. Christopher Ryerson, MD is a pulmonologist in San Francisco, California.
Clinical Trials
- The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease Start of enrollment: 2010 Feb 01
- Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31
Publications & Presentations
PubMed
- 1 citationsThe Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society.Geoffrey D Rubin, Christopher J Ryerson, Linda B Haramati, Nicola Sverzellati, Jeffrey P Kanne
Radiology. 2020-07-01 - 43 citationsDiagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary FibrosisSimon L.F. Walsh, David J. Lederer, Christopher J. Ryerson, Martin Kolb, Toby M. Maher
American Journal of Respiratory and Critical Care Medicine. 2019-11-01 - 2213 citationsDiagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.Ganesh Raghu, Martine Remy-Jardin, Jeffrey L. Myers, Luca Richeldi, Christopher J. Ryerson
American Journal of Respiratory and Critical Care Medicine. 2018-08-31
Press Mentions
Low BMI, Weight Loss Predict Mortality Risk in ILDJanuary 4th, 2022
What the Health?! Can Feather Duvets Really Cause Lung Disease?November 29th, 2019
Transbronchial Lung Cryobiopsy a Valid Diagnostic Option in Interstitial Lung DiseaseOctober 7th, 2019- Join now to see all
